Benzinga's Top Pre-Market Gainers

Illumina Inc

surged 41.30% to $53.25 in the pre-market session. Roche announced its plans to offer $5.7 billion for Illumina. Pacific Biosciences of California Inc

added 26.58% to $5 in the pre-market session. PACB is scheduled to report its quarterly earnings on 13 February. CA Inc

moved up 16.39% to $26.56 in the pre-market session. CA announced its plans to lift its annual dividend to $1 per share. Complete Genomics Inc

soared 14% to $2.85 in the pre-market trading. GNOM shares have dropped 68.51% over the past 52 weeks, while the S&P 500 index has gained 1.49% in the same period.